Tag: drugs

08/05/2017 / / Biotechnology

Insilico Medicine has recently signed a multi-year drug agreement with one of the biotechnology companies Juvenescence AI Limited. Juvenescence AI will be developing the first compounds that were generated by the Insilico’s deep learnings that train over structural, phenotypic, and functional data in accordance to predicting the biological activity of the compounds. The Insilico’s platforms integrate all new Artificial Intelligence¬†techniques like the Generative Adversarial Networks in accordance to generating novel compounds with desired properties like pharmacokinetic and pharmacodynamic.

Read the Post Next-Generation Artificial Intelligence To Be Developed Into Drugs